Outlook Therapeutics Inc (OTLK) USD0.01
Sell:$1.39Buy:$1.47
$0.05
(3.60%)
Prices delayed by at least 15 minutes
- This stock can be held in a
Stocks and Shares ISASell:$1.39
Buy:$1.47
Change:$0.05
(3.60%)
$0.05
(3.60%)Prices delayed by at least 15 minutes
Sell:$1.39
Buy:$1.47
Change:$0.05
(3.60%)
$0.05
(3.60%)Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 26 September 2024 | Lawrence A KenyonCFO | Buy Regular purchase transaction | 5,000 | $5.69 | $28,446.00 | 5,946 |
| 15 April 2024 | SYNTONE VENTURES LLCVenture Capital | Buy Regular purchase transaction | 714,286 | $7.00 | $5,000,002.00 | 1,705,438 |
| 28 March 2024 | Yezan Munther HaddadinDirector | Buy Regular purchase transaction | 1,881 | $11.82 | $22,233.42 | 5,049 |
| 18 March 2024 | GMS VENTURES & INVESTMENTSVenture Capital | Buy Regular purchase transaction | 2,305,714 | $7.00 | $16,139,998.00 | 5,808,074 |
| 7 March 2024 | Jeff EvansonChief Level Officer | Buy Regular purchase transaction | 62,484 | $0.42 | $26,243.28 | 808,459 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 March 2024 | GMS VENTURES & INVESTMENTSVenture Capital | Buy Regular purchase transaction | 2,305,714 | $7.00 | $16,139,998.00 | 5,808,074 |
| 15 April 2024 | SYNTONE VENTURES LLCVenture Capital | Buy Regular purchase transaction | 714,286 | $7.00 | $5,000,002.00 | 1,705,438 |
| 26 September 2024 | Lawrence A KenyonCFO | Buy Regular purchase transaction | 5,000 | $5.69 | $28,446.00 | 5,946 |
| 7 March 2024 | Jeff EvansonChief Level Officer | Buy Regular purchase transaction | 62,484 | $0.42 | $26,243.28 | 808,459 |
| 28 March 2024 | Yezan Munther HaddadinDirector | Buy Regular purchase transaction | 1,881 | $11.82 | $22,233.42 | 5,049 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.